These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 2969114

  • 1. Is there a best endocrine management of prostatic carcinoma?
    Robinson MR.
    Prog Clin Biol Res; 1988; 269():147-58. PubMed ID: 2969114
    [No Abstract] [Full Text] [Related]

  • 2. Lessons from phase III-trials on the hormonal treatment of prostatic cancer. I: Results of EORTC-trials 30761 and 30762.
    de Voogt HJ, Pavone-Macaluso M, Smith PH, de Pauw M, Suciu S.
    Prog Clin Biol Res; 1988; 260():111-7. PubMed ID: 2966403
    [No Abstract] [Full Text] [Related]

  • 3. Cyproterone acetate versus medroxyprogesterone acetate versus diethylstilbestrol in the treatment of prostate cancer: results from EORTC Study 30761.
    Pavone-Macaluso M, Ingargiola GB, de Voogt H, Viggiano G, Barasolo E, Lardennois B, De Pauw M, Sylvester R.
    Prog Clin Biol Res; 1987; 243A():379-82. PubMed ID: 2958862
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of prostatic cancer: medroxyprogesterone acetate, diethylstilbestrol and cyproterone acetate. Provisional report of a random study by the genito-urinary cooperative group of the EORTC].
    Pavone-Macaluso M, Martínez-Piñeiro JA, de Voogt H, Lardennois B, Nasta A, Zolfanelli R, Barasolo E, De Pauw M, Suciu S, Sulvester R.
    Arch Esp Urol; 1982; 35(5):304-11. PubMed ID: 6217788
    [No Abstract] [Full Text] [Related]

  • 5. EORTC protocol 30761: a randomized study of non-metastatic and metastatic prostatic cancer treated by cyproterone acetate versus diethylstilbestrol and medroxyprogesterone acetate. European Organization for Research on Treatment of Cancer Urological Group.
    Pavone-Macaluso M, Schröder FH, de Voogt HJ, Viggiano G, Barasolo E, Lardennois B, de Pauw M, Sylvester R, Smith PH, Suciu S.
    Prog Clin Biol Res; 1989; 303():111-6. PubMed ID: 2528735
    [No Abstract] [Full Text] [Related]

  • 6. The EORTC Phase III trials in prostatic cancer.
    Robinson MR, Smith PH, Macaluso MP, Sylvester R, de Voogt H.
    Prog Clin Biol Res; 1985; 185A():243-9. PubMed ID: 3898132
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of prostatic cancer: the EORTC experience--preliminary results of prostatic carcinoma trials.
    Schroeder FH.
    Prostate; 1984; 5(2):193-8. PubMed ID: 6231535
    [Abstract] [Full Text] [Related]

  • 8. Hormonal therapy of advanced prostatic cancer.
    Fair WR.
    J Urol; 1986 Sep; 136(3):653-4. PubMed ID: 2942708
    [No Abstract] [Full Text] [Related]

  • 9. Re: Cardiovascular side effects of diethylstilbestrol, cyproterone acetate, medroxyprogesterone acetate and estramustine phosphate used for the treatment of advanced prostatic cancer: results from European Organization for Research on Treatment of Cancer Trials 30761 and 30762.
    deVoogt HJ, Pavone-Macaluso M, Sylvester R, Schröder FH.
    J Urol; 1988 Dec; 140(6):1557. PubMed ID: 2973530
    [No Abstract] [Full Text] [Related]

  • 10. EORTC protocol 30805: a phase III trial comparing orchidectomy versus orchidectomy and cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate.
    Robinson MR.
    Prog Clin Biol Res; 1988 Dec; 260():101-10. PubMed ID: 2966402
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of diethylstilbestrol, cyproterone acetate and medroxyprogesterone acetate in the treatment of advanced prostatic cancer: final analysis of a randomized phase III trial of the European Organization for Research on Treatment of Cancer Urological Group.
    Pavone-Macaluso M, de Voogt HJ, Viggiano G, Barasolo E, Lardennois B, de Pauw M, Sylvester R.
    J Urol; 1986 Sep; 136(3):624-31. PubMed ID: 2942707
    [Abstract] [Full Text] [Related]

  • 12. Hormonal therapy trials in prostatic cancer. An EORTC Genitourinary Group study.
    Bollack C, Rougeron G.
    Am J Clin Oncol; 1988 Sep; 11 Suppl 2():S156-9. PubMed ID: 2977270
    [Abstract] [Full Text] [Related]

  • 13. Complete androgen blockade: the EORTC experience comparing orchidectomy versus orchidectomy plus cyproterone acetate versus low-dose stilboestrol in the treatment of metastatic carcinoma of the prostate.
    Robinson MR.
    Prog Clin Biol Res; 1987 Sep; 243A():383-90. PubMed ID: 2958863
    [No Abstract] [Full Text] [Related]

  • 14. Cardiovascular side effects of diethylstilbestrol, cyproterone acetate, medroxyprogesterone acetate and estramustine phosphate used for the treatment of advanced prostatic cancer: results from European Organization for Research on Treatment of Cancer trials 30761 and 30762.
    de Voogt HJ, Smith PH, Pavone-Macaluso M, de Pauw M, Suciu S.
    J Urol; 1986 Feb; 135(2):303-7. PubMed ID: 2935644
    [Abstract] [Full Text] [Related]

  • 15. EORTC protocols in prostatic cancer. An interim report.
    Pavone-Macaluso M, Lund F, Mulder JH, Smith PH, De Pauw M, Sylvester R.
    Scand J Urol Nephrol Suppl; 1980 Feb; 55():163-8. PubMed ID: 6938020
    [Abstract] [Full Text] [Related]

  • 16. Multivariate analysis of prognostic factors in patients with advanced prostatic cancer: results from 2 European Organization for Research on Treatment of Cancer trials.
    de Voogt HJ, Suciu S, Sylvester R, Pavone-Macaluso M, Smith PH, de Pauw M.
    J Urol; 1989 Apr; 141(4):883-8. PubMed ID: 2522561
    [Abstract] [Full Text] [Related]

  • 17. Management of metastatic prostatic carcinoma.
    Drug Ther Bull; 1986 Nov 03; 24(22):85-8. PubMed ID: 2430768
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of prostatic cancer with cyproterone acetate as monotherapy.
    Beurton D, Grall J, Davody P, Cukier J.
    Prog Clin Biol Res; 1987 Nov 03; 243A():369-77. PubMed ID: 2958861
    [No Abstract] [Full Text] [Related]

  • 19. Initial treatment of prostatic cancer by endocrine measures and cytotoxic drugs.
    Tunn UW, Goldschmidt AJ, Peter K, Becker M.
    Prog Clin Biol Res; 1990 Nov 03; 359():165-76; discussion 177-80. PubMed ID: 2149458
    [No Abstract] [Full Text] [Related]

  • 20. Simultaneous endocrine management and chemotherapy as initial treatment in M1 prostatic carcinoma.
    Richards B.
    Prog Clin Biol Res; 1988 Nov 03; 269():177-86. PubMed ID: 2839846
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.